vs
Side-by-side financial comparison of R F INDUSTRIES LTD (RFIL) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
R F INDUSTRIES LTD is the larger business by last-quarter revenue ($22.7M vs $20.6M, roughly 1.1× Entrada Therapeutics, Inc.). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -84.4%, a 85.2% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs -65.2%). R F INDUSTRIES LTD produced more free cash flow last quarter ($2.0M vs $-39.7M). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs 6.4%).
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
RFIL vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.7M | $20.6M |
| Net Profit | $173.0K | $-17.3M |
| Gross Margin | 36.8% | — |
| Operating Margin | 4.0% | -106.0% |
| Net Margin | 0.8% | -84.4% |
| Revenue YoY | 22.9% | -65.2% |
| Net Profit YoY | 172.7% | -173.8% |
| EPS (diluted) | $0.01 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.7M | — | ||
| Q3 25 | $19.8M | — | ||
| Q2 25 | $18.9M | — | ||
| Q1 25 | $19.2M | $20.6M | ||
| Q4 24 | $18.5M | $37.4M | ||
| Q3 24 | $16.8M | $19.6M | ||
| Q2 24 | $16.1M | $94.7M | ||
| Q1 24 | $13.5M | $59.1M |
| Q4 25 | $173.0K | — | ||
| Q3 25 | $392.0K | — | ||
| Q2 25 | $-245.0K | — | ||
| Q1 25 | $-245.0K | $-17.3M | ||
| Q4 24 | $-238.0K | $1.1M | ||
| Q3 24 | $-705.0K | $-14.0M | ||
| Q2 24 | $-4.3M | $55.0M | ||
| Q1 24 | $-1.4M | $23.5M |
| Q4 25 | 36.8% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 29.8% | — | ||
| Q4 24 | 31.3% | — | ||
| Q3 24 | 29.5% | — | ||
| Q2 24 | 29.9% | — | ||
| Q1 24 | 24.5% | — |
| Q4 25 | 4.0% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.3% | -106.0% | ||
| Q4 24 | 0.5% | -15.7% | ||
| Q3 24 | -2.5% | -110.7% | ||
| Q2 24 | -2.6% | 56.4% | ||
| Q1 24 | -15.5% | 35.7% |
| Q4 25 | 0.8% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -1.3% | -84.4% | ||
| Q4 24 | -1.3% | 3.0% | ||
| Q3 24 | -4.2% | -71.7% | ||
| Q2 24 | -26.7% | 58.1% | ||
| Q1 24 | -10.1% | 39.7% |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.04 | — | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $-0.02 | $-0.42 | ||
| Q4 24 | $-0.02 | $-0.20 | ||
| Q3 24 | $-0.07 | $-0.35 | ||
| Q2 24 | $-0.41 | $1.55 | ||
| Q1 24 | $-0.13 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.2M | $417.3M |
| Total Assets | $73.0M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $1.3M | $67.8M | ||
| Q4 24 | $839.0K | $101.2M | ||
| Q3 24 | $1.8M | $78.0M | ||
| Q2 24 | $1.4M | $185.3M | ||
| Q1 24 | $4.5M | $68.4M |
| Q4 25 | $35.2M | — | ||
| Q3 25 | $34.8M | — | ||
| Q2 25 | $34.2M | — | ||
| Q1 25 | $34.2M | $417.3M | ||
| Q4 24 | $34.1M | $428.7M | ||
| Q3 24 | $34.1M | $422.4M | ||
| Q2 24 | $34.6M | $429.9M | ||
| Q1 24 | $38.7M | $269.4M |
| Q4 25 | $73.0M | — | ||
| Q3 25 | $73.2M | — | ||
| Q2 25 | $72.7M | — | ||
| Q1 25 | $70.4M | $486.5M | ||
| Q4 24 | $71.0M | $526.3M | ||
| Q3 24 | $71.9M | $554.6M | ||
| Q2 24 | $72.8M | $582.0M | ||
| Q1 24 | $79.1M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.1M | $-38.5M |
| Free Cash FlowOCF − Capex | $2.0M | $-39.7M |
| FCF MarginFCF / Revenue | 9.0% | -192.9% |
| Capex IntensityCapex / Revenue | 0.3% | 5.6% |
| Cash ConversionOCF / Net Profit | 12.13× | — |
| TTM Free Cash FlowTrailing 4 quarters | $4.3M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.1M | — | ||
| Q3 25 | $-311.0K | — | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $601.0K | $-38.5M | ||
| Q4 24 | $-244.0K | $-31.6M | ||
| Q3 24 | $2.4M | $-24.3M | ||
| Q2 24 | $197.0K | $39.8M | ||
| Q1 24 | $840.0K | $-25.5M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-419.0K | — | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $574.0K | $-39.7M | ||
| Q4 24 | $-418.0K | $-32.2M | ||
| Q3 24 | $2.1M | $-24.9M | ||
| Q2 24 | $28.0K | $38.8M | ||
| Q1 24 | $697.0K | $-26.4M |
| Q4 25 | 9.0% | — | ||
| Q3 25 | -2.1% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 3.0% | -192.9% | ||
| Q4 24 | -2.3% | -86.2% | ||
| Q3 24 | 12.6% | -127.3% | ||
| Q2 24 | 0.2% | 41.0% | ||
| Q1 24 | 5.2% | -44.6% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | 5.6% | ||
| Q4 24 | 0.9% | 1.7% | ||
| Q3 24 | 1.5% | 3.3% | ||
| Q2 24 | 1.0% | 1.1% | ||
| Q1 24 | 1.1% | 1.4% |
| Q4 25 | 12.13× | — | ||
| Q3 25 | -0.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
TRDA
Segment breakdown not available.
